Avalyn Pharma Inc. · NASDAQ:AVLN
SR One Capital Management, LLC reported a 7.50% stake in Avalyn Pharma Inc. (Schedule 13D)
Event May 1, 2026 · Filed May 8, 2026
SR One Capital Management, LLC reported a 7.50% stake in Avalyn Pharma Inc., 3,308,649 shares, with active intent on May 1, 2026. Filed May 8, 2026 (Schedule 13D).
- Stake
- 7.50%
- Shares
- 3,308,649
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SR One Capital Management, LLC | 7.50% | 3,308,649 |
| SR One Capital Fund II Aggregator, LP | 4.90% | 2,186,562 |
| SR One Capital Partners II, LP | 4.90% | 2,186,562 |
| AMZL, LP | 2.50% | 1,122,087 |
| SR One Capital SMA Partners, LP | 2.50% | 1,122,087 |
| Simeon George | 7.50% | 3,308,649 |
Source
Related
- Avalyn Pharma Inc.
- SR One Capital Management, LLC
- Avalyn Pharma Inc. shareholders
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Norwest Venture Partners XV, LP · Aug 11, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D · Montanova Capital, LLC · May 8, 2026
- Schedule 13G · Perceptive Advisors LLC · May 7, 2026